WR
PAVM icon

Watson Rebecca’s PAVmed PAVM Stock Holding History

Watson Rebecca’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7
Closed -$7K – 278
2020
Q2 		$7K Buy
+7
New +$7K ﹤0.01% 280

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VWM
Vigilare Wealth Management Scottsdale, Arizona $326M AUM 21.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Watson Rebecca's PAVM Position: Q3 2020 in Review

Watson Rebecca sold out of PAVmed (PAVM) in Q3 2020, closing a stake of 7 shares — an estimated $7K sold.

Watson Rebecca first reported a position in PAVM in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 60 funds tracked by Wall St. Rank hold PAVM as of Q3 2020.

  • Watson Rebecca reported no remaining PAVmed position as of Q3 2020 after selling out during the quarter.
  • Watson Rebecca sold 7 PAVmed shares in Q3 2020, an estimated $7K.
  • Watson Rebecca first reported a position in PAVmed in Q2 2020 and held it in 1 quarter.
  • Watson Rebecca's PAVmed position peaked at $7K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held PAVmed as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.